Director sale: UVE (NYSE: UVE) files to sell 20,000 shares on 06/11/2026
Rhea-AI Filing Summary
UVE-related filing reports a proposed sale of 20,000 common shares on 06/11/2026. The filing lists the sale as Lieu Compensation to be effected for cash through Raymond James & Associates. The notice also lists three prior sales of 20,000 shares each on 03/25/2026, 04/29/2026, and 05/15/2026 with transaction proceeds shown.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies a planned insider sale of 20,000 shares on 06/11/2026.
The notice identifies the sales method as cash disposition and the stated reason as Lieu Compensation. The excerpt lists broker details (Raymond James & Associates) and an aggregate transaction value for the 20,000 shares.
Past sales of 20,000 shares on 03/25/2026, 04/29/2026, and 05/15/2026 are shown with their proceeds; timing and routing imply routine planned dispositions. Cash‑flow treatment: proceeds payable to the selling holder as disclosed in the excerpt.